Aerska

Neumirna Therapeutics

This biotechnology company develops microRNA-based therapies to treat patients with neurological disorders, including drug-resistant epilepsy and Parkinson's disease.

Averna Therapeutics

This biotechnology company develops genomic medicines using RNA-based technology to insert therapeutic genes into safe genomic locations for patients with various diseases.

Biorchestra

The company develops RNA-based medicines and delivery systems for patients with neurodegenerative and rare central nervous system diseases.

Aliada Therapeutics

This company develops blood-brain barrier crossing technologies and antibody therapies for patients with central nervous system diseases including Alzheimer's.

Aera Therapeutics

This biotechnology company develops delivery platforms for genetic medicines to treat various diseases for biopharmaceutical partners and patients.

Crucible Therapeutics

This biotechnology company develops RNA-based therapies for patients with neurodegenerative conditions such as amyotrophic lateral sclerosis and frontotemporal dementia.

Travin

This company develops blood-brain barrier shuttles for RNA therapeutics to enable the treatment of neurological diseases.

Alector

This biopharmaceutical company develops therapies for neurodegenerative diseases using a blood-brain barrier delivery platform for patients with conditions including ALS and Parkinson’s.